Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia

Carolyn M. Larsen, Hector R. Villarraga, Kebede H. Begna, Mark R. Litzow, Aref Al-Kali, Joerg Herrmann

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia'. Together they form a unique fingerprint.